Evidence map›Paper›PMID 35581406›Full record

ArticleBone marrow transplantation2022

Racial disparities in time to hematopoietic cell transplant among patients with hematologic malignancies at a large urban academic center.

Harsh Shah, Seongho Kim, Scott Klimecki, Karl Charlson, Joseph Uberti, Charles A Schiffer, Mark A Fiala, Erlene Seymour

Abstract readLetter
In one paragraph

Article in Bone marrow transplantation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Access to Transplant Care and Social Determinants of Health.Advances in experimental medicine and biology · 2025
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Harsh ShahDepartment of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, MI, USA. harsh.shah@hci.utah.edu.ORCID http://orcid.org/0000-0001-6054-5238
Seongho KimDepartment of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, MI, USA.
Scott KlimeckiDepartment of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, MI, USA.
Karl CharlsonWanye State Universitiy School of Medicine, Detroit, MI, USA.
Joseph UbertiDepartment of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, MI, USA.
Charles A SchifferDepartment of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, MI, USA.
Mark A FialaDepartment of Oncology, Washington University School of Medicine, Saint Louis, MO, USA.ORCID http://orcid.org/0000-0002-0208-5023
Erlene SeymourDepartment of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, MI, USA.

Funding

Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI PAUL M STEMMER · 1985 to 2026
$68.4M
NCI NIH HHS P30 CA022453
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematologic NeoplasmsHematopoietic Stem Cell TransplantationTransplantsHumans

Identifiers

PMID35581406
PMCPMC9665109

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.